ArticleGland surgery2025
DCE-MRI-based machine learning model for predicting axillary lymph node metastasis in breast cancer.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Evaluation of Combined Diffusion Kurtosis Imaging and Intravoxel Incoherent Motion Diffusion Weighted Imaging in Preoperatively Predicting Sentinel Lymph Node Metastasis of Breast Cancer.International journal of general medicine · 2026Article
- Predictive value of multiparametric magnetic resonance imaging combined with pathological biomarkers for axillary lymph node metastasis of breast cancer.Gland surgery · 2025Article
- Noninvasive prediction of microsatellite instability in stage II/III rectal cancer using dynamic contrast-enhanced magnetic resonance imaging radiomics.World journal of gastrointestinal oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate evaluation of the axillary lymph node (ALN) status is needed for determining the treatment protocol for breast cancer. This study aimed to build an artificial intelligence (AI) model to predict ALN metastasis based on pre-treatment dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) of breast cancer combined with radiomics algorithms. Methods: Pre-treatment DCE-MRI dataset of 166 patients with pathologically confirmed breast cancer diagnosis from January 2017 to August 2020 was collected, and all patients were randomly divided into a training group and test group with a ratio of 7:3. Each patient underwent pre-enhancement as well as post-enhancement 1-6 MRI, and a total of 7,224 two-dimensional (2D) and 9,863 three-dimensional (3D) features were extracted, respectively. Radiomics models based on 2D, 3D, pre-enhancement, and the first post-enhancement images were established using the least absolute shrinkage selection operator (LASSO) algorithm based on machine learning, and the area under the curve (AUC), accuracy, sensitivity, and specificity of the models were calculated. Results: The mean AUC, accuracy, sensitivity, and specificity of the 10-fold cross-validation of the 3D radiomics-based model were 82%, 82%, 83%, and 81%, respectively. The C-index of the combined model with combining radiomics features and clinical features was 90%, the AUC was 90%, the specificity was 91%, the sensitivity was 77% and the accuracy was 84%. Conclusions: The comprehensive prediction model using DCE-MRI image combined with clinical features can accurately predict ALN metastasis in breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.